THRX · Categories · Form 4

THRX - SEC Form 4 insider transactions

Theseus Pharmaceuticals Inc. (THRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for THRX

• 847d
  SEC Form 4 filed by Yi Kathy

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 847d
  SEC Form 4 filed by Stein Steven H

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 847d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 847d
  Hayden Donald J Jr closing all direct ownership in the company (SEC Form 4)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 847d
  Dukes Iain D. closing all direct ownership in the company (SEC Form 4)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 847d
  SEC Form 4 filed by Gordon Carl L

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 847d
  Dahms Bradford D. closing all direct ownership in the company (SEC Form 4)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 946d
  Shakespeare William exercised 251,084 shares at a strike of $0.32, increasing direct ownership by 65% to 639,408 units (SEC Form 4)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1057d
  SEC Form 4 filed by Gordon Carl L

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1057d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1057d
  SEC Form 4 filed by Foresite Capital Management V, Llc

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1093d
  SEC Form 4 filed by Yi Kathy

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1093d
  SEC Form 4 filed by Stein Steven H

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1093d
  SEC Form 4 filed by Hayden Donald J Jr

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1093d
  SEC Form 4 filed by Gordon Carl L

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1093d
  SEC Form 4 filed by Dukes Iain D.

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1197d
  SEC Form 4 filed by Rivera Victor

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1197d
  SEC Form 4 filed by Shakespeare William

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1197d
  SEC Form 4 filed by Kerstein David

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1197d
  SEC Form 4 filed by Dahms Bradford D.

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1197d
  SEC Form 4 filed by Clackson Timothy P

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1206d
  SEC Form 4 filed by Shakespeare William

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1206d
  SEC Form 4 filed by Rivera Victor

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1206d
  SEC Form 4 filed by Kerstein David

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1206d
  SEC Form 4 filed by Dahms Bradford D.

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1206d
  SEC Form 4 filed by Clackson Timothy P

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1254d
  SEC Form 4: Foresite Capital Management V, Llc bought $2,500,000 worth of shares (500,000 units at $5.00)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1255d
  SEC Form 4: Hayden Donald J Jr bought $49,989 worth of shares (10,000 units at $5.00)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1287d
  SEC Form 4: Dahms Bradford D. bought $10,000 worth of shares (1,502 units at $6.66), increasing direct ownership by 32% to 6,142 units

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1304d
  SEC Form 4: Clackson Timothy P bought $16,995 worth of shares (2,500 units at $6.80), increasing direct ownership by 0.72% to 351,030 units

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1309d
  SEC Form 4: Gordon Carl L bought $1,000,320 worth of shares (192,000 units at $5.21)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1309d
  SEC Form 4: Orbimed Advisors Llc bought $1,000,320 worth of shares (192,000 units at $5.21)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1331d
  SEC Form 4 filed by Stein Steven H

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1458d
  SEC Form 4 filed by Yi Kathy

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1458d
  SEC Form 4 filed by Dukes Iain D.

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1458d
  SEC Form 4 filed by Gordon Carl L

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1484d
  SEC Form 4 filed by Hayden Donald J Jr

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1568d
  SEC Form 4 filed by Kerstein David

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1568d
  SEC Form 4 filed by Clackson Timothy P

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1568d
  SEC Form 4 filed by Dalgarno David

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1568d
  SEC Form 4 filed by Rivera Victor

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1568d
  SEC Form 4 filed by Shakespeare William

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1568d
  SEC Form 4 filed by Dahms Bradford D.

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1601d
  SEC Form 4: Gordon Carl L bought $1,578,717 worth of shares (158,417 units at $9.97)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1601d
  SEC Form 4: Orbimed Advisors Llc bought $1,578,717 worth of shares (158,417 units at $9.97)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1609d
  SEC Form 4: Gordon Carl L bought $442,750 worth of shares (44,717 units at $9.90)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1609d
  SEC Form 4: Orbimed Advisors Llc bought $442,750 worth of shares (44,717 units at $9.90)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1631d
  SEC Form 4: Clackson Timothy P bought $25,381 worth of shares (2,600 units at $9.76), increasing direct ownership by 0.75% to 348,530 units

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)
• 1631d
  SEC Form 4: Dahms Bradford D. bought $20,000 worth of shares (1,970 units at $10.15)

  4 - Theseus Pharmaceuticals, Inc. (0001745020) (Issuer)

Other THRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends